Successful treatment of Afatinib plus Apatinib using for a lung adenocarcinoma patient with HER-2 V659D mutation: a rare case report

Sun, C; Xu, YH; Wang, X; Guo, Y; Qiu, S; Shao, GG; Yang, ZG; Liu, YP; Zhang, P; Ma, KW

Ma, KW (corresponding author), First Hosp Jilin Univ, Canc Ctr, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China.

ANTI-CANCER DRUGS, 2021; 32 (4): 469

Abstract

Lung cancer is one of the most important and lethal cancers in the world. Human epidermal growth factor 2 (HER2) is a member of the erbB receptor tyro......

Full Text Link